
Curio Biotech
Visp, Switzerland curiobiotech.com From their website, Nov 2026
Work here? Claim this listing
About
Curio Biotech is a human-biology-focused in vitro CRO in Visp, Switzerland. It supports drug discovery and development with primary human cell culture, 3D tissue-engineered models, and ex vivo systems for pharma and cosmetics clients.
Services
High-throughput screening
Screening studies using human-relevant in vitro platforms for early discovery decisions.
Efficacy studies
Studies to assess biological response and efficacy in human-based models.
Mechanism-of-action (MoA) and pathway analysis
Analyses to investigate mechanism of action and signaling pathways.
Safety assays
In vitro safety assessment using primary human cell and tissue models.
DMPK-relevant assays
Assays supporting drug metabolism and pharmacokinetics-related evaluation.
ADME, DMPK & toxicology
Biomarker discovery, identification and validation
Discovery, identification, and validation of biomarkers for translational studies.
Biopharma-related bioassays
Bioassays supporting biopharmaceutical research and development.
siRNA inhibition
Functional perturbation studies using siRNA inhibition.
15 more services
- Multiplex qPCR
- ELISA
- ICC
- IHC
- Transcriptomics
- Proteomics
- Lipidomics
- Metabolomics
- High-throughput screening and efficacy studies
- Mechanism-of-action and pathway analysis
- Biomarker identification and validation
- Screening platforms using primary human cells
- Advanced 3D tissue-engineered model studies
- Ex vivo system studies
- siRNA inhibition studies
Capabilities
- Assays and studies
- ELISA
- qPCR
- HTS
- Screening
- Efficacy
- Mechanism-of-action
12 more
- Pathway analysis
- Safety
- DMPK
- Biomarker discovery
- Biomarker validation
- High-throughput screening
- Biopharma bioassays
- siRNA inhibition
- Multiplex qPCR
- ICC
- IHC
- Transcriptomics
- Therapeutic areas
- Dermatology
- Aging
- Inflammation
- Immuno-Oncology
- Vascular Biology
- Autoimmune Diseases
4 more
- Metabolism
- Regenerative Biology
- Anti-aging
- PCSK9 inhibitors
Modalities and species
- Modalities
- Oligonucleotide
- Species and models
- Primary human cells
- Primary human tissues
- 3D tissue-engineered models
- Ex vivo systems
- Human tissues
Industries served
- Pharma
- Cosmetics
- Biotech
Company
- Type
- CRO
- Founded
- 2017
- Quality
- 3R principles · New Approach Methodologies (NAMs) · FDA Modernization Act 2.0
Locations
- Address
- Rottenstrasse 5 3930 Visp (VS), Switzerland
- Sites
- Visp (VS), Switzerland
- Valais, Switzerland
- Serves
- Three continents
Contacts
- Phone
- +41 27 508 5802